GLOBO Language Solutions Named Semifinalist in Massachusetts Primary Care Innovation Challenge
Company is among 24 U.S. semifinalists selected to advance in a competition focused on reducing administrative burden, workforce burnout, and access barriers in primary care
GLOBO Language Solutions has been named one of 24 U.S. semifinalists selected to advance in the Primary Care Innovation Challenge, hosted by the Massachusetts Technology Collaborative’s Massachusetts eHealth Institute (MeHI).
According to the announcement, 24 semifinalists were chosen from a pool of 70 applicants. The challenge supports digital health innovations aimed at addressing operational and access-related issues in primary care, including administrative burden, workforce burnout, and patient access. Finalists will compete for $300,000 in grant funding.
GLOBO said it plans to use the opportunity to further evaluate its AI healthcare interpreter in primary care environments. The company’s proposed pilot approach includes sending human interpreters on-site to observe and assess how the AI tool performs in low-risk, real-world care scenarios. The stated goal is to identify use cases for expanding language support for patients with limited English proficiency while reducing in-person workload and easing capacity constraints.
The Primary Care Innovation Challenge is the fourth iteration of the Massachusetts Digital Health Sandbox Challenge, a program designed to connect digital health companies with research and development facilities, or “sandboxes,” to support product development and market growth.
The challenge also aligns with the objectives of the Massachusetts Primary Care Access, Delivery and Payment Task Force, which was established in 2025 and is co-chaired by the Health Policy Commission and the Massachusetts Executive Office of Health and Human Services.
In a statement, MeHI Director Keely Benson said the semifinalists represent a group of digital health startups developing solutions for clinical settings, and that the program aims to connect those companies with research and academic institutions to help address current challenges in primary care.
